The timing of your injection is strategic, designed to work with your bodys natural cycle of GH secretion
If you are pregnant, breastfeeding, or have specific medical concernssuch as kidney disease, low potassium levels, or certain blood disordersplease mention these during your consultation
This product is intended exclusively for laboratory, educational, and scientific research applications
Due to its plasma half-life of approximately 3.8-6.9 hours, a twice-daily (BID) dosing schedule may be used to provide more consistent and sustained inhibition of NNMT throughout the day, potentially maximizing its metabolic effects
It does not make the peptide immune to degradation
, Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation, J